Clene - Stock Price History | CLNN

Historical daily share price chart and data for Clene since 2021 adjusted for splits. The latest closing stock price for Clene as of September 24, 2021 is 7.08.
  • The all-time high Clene stock closing price was 16.30 on February 16, 2021.
  • The Clene 52-week high stock price is 17.82, which is 151.7% above the current share price.
  • The Clene 52-week low stock price is 6.23, which is 12% below the current share price.
  • The average Clene stock price for the last 52 weeks is 10.30.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Clene Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 10.7499 10.4844 12.9700 9.0100 9.0100 -14.06%
2019 10.2055 9.9000 10.4900 9.9000 10.4844 5.90%
2018 9.7670 9.6500 9.9300 9.6300 9.9000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.446B $0.000B
Clene Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of unique therapeutics for neurodegenerative diseases. Clene Nanomedicine Inc., formerly known as Tottenham Acquisition I Limited, is based in SALT LAKE CITY.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71